Effects of Tirzepatide on Patients With Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Retrospective Cohort Study.

Cureus · 2025 · PMC12145500 · PMID 40486301

Europe PMC DOI

hedged sentences

0.0640

closest p · 1.3× alpha

0.0640

boldest claim

The sentences

a trend toward significancep = 0.064so close (0.05 < p ≤ 0.1)

showed a trendp = 0.064so close (0.05 < p ≤ 0.1)

While neither factor reached statistical significance in the multiple regression model, age before the switch showed a trend toward significance as a potential predictor of fatty liver index reduction (p = 0.064).

also in 2,499 other papers

may be significantno p-value reported

Therefore, our finding that the concomitant use of an SGLT2i does not suppress the therapeutic effects of tirzepatide may be significant.

also in 7,483 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.